HHLR ADVISORS, LTD.HHLR ADVISORS, LTD.

Institutional investor · Portfolio as of Q2 2025

SEC EDGAR SourceSEC Filings

Top Holdings36 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
PDDPDD
ADR

PDD HOLDINGS INC

7M$730.2M23.5%$110.39-4.76%
13 qtrssince 2022-Q2
Increased
66
FUTUFUTU
ADR

FUTU HLDGS LTD

4.3M$532.9M17.2%$95.17+27.38%
5 qtrssince 2024-Q2
Increased
62

WEBULL CORP

33.1M$395.6M12.7%$10.830.00%
1 qtr
New
97
ONCONC
ADR

BEIGENE LTD-ADR

1M$250.4M8.1%$134.02+79.97%
27 qtrssince 2018-Q4
Unchanged
0
NTESNTES
ADR

NETEASE INC-ADR

1.7M$223.9M7.2%$90.38+45.55%
11 qtrssince 2022-Q4
Decreased
0
LEGNLEGN
ADR

Legend Biotech Corp. Sponsored ADR

6M$212.4M6.8%$50.33-31.19%
21 qtrssince 2020-Q2
Unchanged
0
BEKEBEKE
ADR

KE HOLDINGS INC-ADR

7.5M$132.4M4.3%$21.74-14.71%
20 qtrssince 2020-Q3
Decreased
0
BABABABA
ADR

ALIBABA GROUP HOLDING-SP ADR

1.1M$130.4M4.2%$83.58+34.46%
13 qtrssince 2022-Q2
Decreased
0

ARRIVENT BIOPHARMA INC

4.5M$97.6M3.1%$17.95+27.66%
6 qtrssince 2024-Q1
Unchanged
0
WNSWNSDelisted

WNS HLDGS LTD

1.5M$96.8M3.1%
3 qtrssince 2024-Q4
Unchanged
0
JDJD
ADR

JD.COM INC-ADR

2.3M$74.3M2.4%$39.67-28.16%
27 qtrssince 2018-Q4
Decreased
0
YSYSG
ADR

YATSEN HLDG LTD

6.1M$58.9M1.9%$10.59-2.18%
19 qtrssince 2020-Q4
Decreased
0
CWANCWANDelisted

CLEARWATER ANALYTICS HDS-A

1.4M$30M1.0%$22.000.00%
1 qtr
New
57

CYTEK BIOSCIENCES INC

6.7M$22.6M0.7%$20.96-83.06%
16 qtrssince 2021-Q3
Unchanged
0
VIPSVIPS
ADR

VIPSHOP HLDGS LTD

1.1M$17M0.5%$12.69+19.11%
18 qtrssince 2021-Q1
Decreased
0
LILI
ADR

LI AUTO INC

620,000$16.8M0.5%$25.52-51.37%
2 qtrssince 2025-Q1
Unchanged
0
NBPNBP
ADR

NOVABRIDGE BIOSCIENCES

6M$14.5M0.5%$47.24-94.56%
20 qtrssince 2020-Q3
Unchanged
0
ZTOZTO
ADR

ZTO EXPRESS CAYMAN INC

671,387$11.9M0.4%$22.17+3.28%
10 qtrssince 2023-Q1
Unchanged
0
BZBZ
ADR

KANZHUN LIMITED

576,339$10.3M0.3%$19.32-19.51%
2 qtrssince 2025-Q1
Unchanged
0
APIAPI
ADR

AGORA INC

2.1M$8M0.3%$4.20-10.00%
3 qtrssince 2024-Q4
Unchanged
0
$3.1B
AUM
36
Positions
Q2 2025
Filing
Rating · 2.0
Quarterly Portfolio Change
-7%Q1'24$4.6B-12%Q2'24$4.1B+12%Q3'24$4.6B-37%Q4'24$2.9B+23%Q1'25$3.5B-12%Q2'25$3.1B
Activity profile
$ moved · Q2'25
New28%Increased9%Decreased51%Exited12%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.7 years
<1Q6%1-4Q11%1-2Y17%2Y+67%

HHLR ADVISORS, LTD. manages $3.1B across 36 positions as of Q2 2025. Top holdings: PDD (23.5%), FUTU (17.2%), BULL (12.7%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 2/5.0.

Q2 2025 Summary

Active quarter - 2 new positions, 15 exits, 2 increased. Top move: BULL (NEW, conviction 97). Portfolio: $3.1B across 36 positions.

Top holdings by portfolio weight

Total AUM$3B
PDD23.52%
FUTU17.17%
BULL12.74%
ONC8.06%
NTES7.21%
LEGN6.84%
BEKE4.27%
BABA4.20%
AVBP3.14%
WNS3.12%
Other2.39%

Portfolio allocation by GICS sector

Sectors9
Consumer Cyclical31.41%
Healthcare19.94%
Financial Services17.24%
Technology14.08%
Communication Services7.54%
Real Estate4.27%
Unknown3.18%
Consumer Defensive1.90%
Industrials0.44%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Consumer Cyclical, Healthcare, Financial Services
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track Record35
Conviction42
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used